anti-PD1

Management of toxicities related to immunotherapies

Number 86

Grandround 30 May 2019 0

Immunotherapy agents are being used to treat a growing range of cancers, but emerging evidence from randomised trials and clinical practice shows very different patterns of toxicity compared to chemotherapy. Jean-Marie Michot reviews what doctors [more]

Gut response: Does benefit from immunotherapy depend on the bacteria in our intestines?

Number 82

Cutting Edge, Featured 25 May 2018 0

A spate of recent studies suggest that differences in population of bacteria and other micro-organisms that inhabit our intestines may be a key factor differentiating between people who respond to immune checkpoint inhibitors and those [more]